[1]
M. J. Cork, B. Lockshin, A. . Pinter, Z. Chen, B. . Shumel, and R. . Prescilla, “Clinically Meaningful Responses to Dupilumab Among Children Aged 6 Months to 5 Years with Moderate-to-severe Atopic Dermatitis who did Not Achieve Clear or Almost Clear Skin According to the Investigator’s Global Assessment: A Post Hoc Analysis of a Phase 3 Trial”, Acta Derm Venereol, vol. 104, p. adv13467, Feb. 2024.